These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36835983)

  • 21. Genetics and Epigenetics of Diabetic Nephropathy.
    Liu R; Lee K; He JC
    Kidney Dis (Basel); 2015 May; 1(1):42-51. PubMed ID: 27536664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNAs associate with diabetic nephropathy and systemic microvascular damage and normalize after simultaneous pancreas-kidney transplantation.
    Bijkerk R; Duijs JM; Khairoun M; Ter Horst CJ; van der Pol P; Mallat MJ; Rotmans JI; de Vries AP; de Koning EJ; de Fijter JW; Rabelink TJ; van Zonneveld AJ; Reinders ME
    Am J Transplant; 2015 Apr; 15(4):1081-90. PubMed ID: 25716422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
    Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
    Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Cooperative Gene Regulation Among Transcription Factors, LncRNAs, and MicroRNAs in Diabetic Nephropathy Progression.
    Chen L; Wu B; Wang S; Xiong Y; Zhou B; Cheng X; Zhou T; Luo R; Lam TW; Yan B; Chen J
    Front Genet; 2020; 11():1008. PubMed ID: 33088282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Li H; Zhu X; Zhang J; Shi J
    Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of novel biomarkers in predicting diabetic nephropathy: a review.
    Uwaezuoke SN
    Int J Nephrol Renovasc Dis; 2017; 10():221-231. PubMed ID: 28860837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.
    Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D
    BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of P4HB as a novel autophagy-related biomarker in diabetic nephropathy.
    Bai F; Yu K; Yang Y; Zhang Y; Ding L; An X; Feng F; Sun N; Fan J; Liu L; Yang H; Yang X
    Front Genet; 2022; 13():965816. PubMed ID: 36226178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy.
    Chen J; Zhang Q; Liu D; Liu Z
    Metabolism; 2021 Sep; 122():154834. PubMed ID: 34217734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy.
    Liu S; Wu W; Liao J; Tang F; Gao G; Peng J; Fu X; Zhan Y; Chen Z; Xu W; Zhao S
    Front Endocrinol (Lausanne); 2022; 13():895010. PubMed ID: 35865316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prevalence and Management of Diabetic Nephropathy in Asia.
    Tomino Y; Gohda T
    Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.